Rafał Wilczyński

Rafał Wilczyński

Auto-generated profile, based on publicly available information

Rafał Wilczyński

Independent Researcher

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2026 in Health Problems of Civilization
Verified
Journal Article
Open access
PDF file
RWRafał Wilczyński
Rafał Wilczyński
WWWiktoria Wdowiak
Wiktoria Wdowiak
WWWeronika Wrona
Weronika Wrona
JOJulia Owsik
Julia Owsik
HLHanna Ludwisiak
Hanna Ludwisiak
MDMałgorzata Dorożalska
Małgorzata Dorożalska
Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) in athletes are rare but catastrophic events that generate substantial medical, ethical, and public health concern. Although regular physical activity is associated with significant cardiovascular benefits, intense training and competition may unmask underlying structural or electrical heart diseases in susceptible individuals. The most common causes of SCA and SCD in young athletes include hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, left ventricular hypertrophy, myocarditis, congenital coronary artery anomalies, and primary electrical disorders such as long QT syndrome. In athletes over 35 years of age, asymptomatic atherosclerotic cardiovascular disease predominates. Pre-participation cardiovascular screening, including medical history, physical examination, and, in some regions, electrocardiography (ECG) aims to identify individuals at risk. However, controversy persists regarding the sensitivity, specificity, cost-effectiveness, and potential for false-positive findings associated with screening strategies. Rapid recognition of SCA, immediate cardiopulmonary resuscitation, and early defibrillation with automated external defibrillators (AEDs) remain critical determinants of survival. The aim of this review is to summarize current evidence on the epidemiology, risk stratification, screening strategies, and emergency management of SCA and SCD in athletes and to highlight ongoing challenges and areas for future research.

8 July 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
SWSzymon Wróbel
Szymon Wróbel
KWKamil Andrzej Wiązania
Kamil Andrzej Wiązania
RWRafał Wilczyński
Rafał Wilczyński
WWWeronika Wrona
Weronika Wrona
MDMałgorzata Dorożalska
Małgorzata Dorożalska
HLHanna Ludwisiak
Hanna Ludwisiak
Background. With the continuous development of new technologies, especially digital technologies, the possibilities provided by telehealth continue to increase. Research shows that the use of telehealth tools can be successfully used for managing patients with chronic conditions. Aim. As the number of chronic conditions within the world’s population rises, their effect becomes evident in terms of lowering patients’ quality of life and life expectancy. Telehealth can be an effective solution to this growing problem. This review is intended to examine the state-of-the-art studies in relation to the effect of telehealth on chronic disorder management, focusing mainly on clinical outcomes, quality of life, and healthcare costs. Material and methods. We reviewed the available scientific literature in databases such as PubMed, Scopus, and Web of Science. We included original research studies, systematic reviews, and meta-analyses that examined the impact of telehealth technologies on the management of patients with chronic diseases and were published in Polish or English between January 2020 and May 2026. Results. From the cited literature, it is clear that the use of telehealth has shown effectiveness in managing chronic disease. Although positive results can be observed in the short-term control of diseases such as hypertension, heart failure, diabetes, asthma, and chronic obstructive pulmonary disease, the effects of long-term management are unknown. Conclusions. This narrative review provides important insights regarding both the possible benefits and constraints of telehealth when managing chronic diseases. With the increasing use of telemedicine, it is vital to consider such difficulties and make sure that telehealth is accessible and efficient for all chronic patients.

28 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MPMaja Maria Porazko
Maja Maria Porazko
KHKrzysztof Sebastian Habirek
Krzysztof Sebastian Habirek
AŻAnna Katarzyna Żurakowska-Zadrożna
Anna Katarzyna Żurakowska-Zadrożna
KWKamil Andrzej Wiązania
Kamil Andrzej Wiązania
RWRafał Wilczyński
Rafał Wilczyński
MPMichał Mieczysław Parus
Michał Mieczysław Parus
Dermal filler procedures have gained widespread popularity in aesthetic medicine due to their accessibility, relatively low cost, and minimal recovery time. However, with increased demand, reports on complications and adverse reactions have also risen. They range from mild, self-limiting cases to rare, severe, and potentially irreversible outcomes. This article reviews the various types of dermal fillers, their mechanisms of action, and details the spectrum of complications—including local site reactions, complications of aesthetic character, infectious, immune-mediated, and vascular events—while highlighting the importance of correct technique, patient selection, and the constant need for ongoing clinician education. The need for evidence-based protocols and clear guidelines is emphasized to enhance patient safety and optimize outcomes in filler-based aesthetic procedures.

16 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KWKamil A. Wiązania
Kamil A. Wiązania
SWSzymon Wróbel
Szymon Wróbel
RWRafał Wilczyński
Rafał Wilczyński
MPMaja Porażko
Maja Porażko
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurrent painful nodules, abscesses, and sinus tracts, resulting in substantial impairment of quality of life. Advances in the understanding of HS immunopathogenesis have led to the development of biologic therapies targeting key inflammatory pathways, particularly TNF-α and IL-17. To summarize current evidence regarding approved biologic therapies for moderate-to-severe HS, focusing on their mechanisms of action, efficacy, safety, and clinical applicability. A narrative literature review was conducted using the PubMed/MEDLINE database. Studies published between January 2016 and June 2026 were screened using the terms “hidradenitis suppurativa”, “adalimumab”, “secukinumab”, “bimekizumab”, and names of pivotal clinical trials. Randomized controlled trials, extension studies, real-world evidence reports, and high-quality reviews were included. Data were qualitatively synthesized. Adalimumab, the first approved biologic for HS, demonstrated significant efficacy in the phase III PIONEER I and II trials, with sustained long-term benefits. Secukinumab showed superior clinical response rates compared with placebo in the phase III SUNSHINE and SUNRISE studies. Bimekizumab demonstrated promising efficacy in both phase II and phase III BE HEARD trials, improving disease activity, pain, and quality of life. Overall, biologic therapies targeting TNF-α and IL-17 pathways consistently improved clinical outcomes in patients with moderate-to-severe HS. Adalimumab remains the established first-line biologic agent, while secukinumab and bimekizumab provide effective alternatives for patients with poor response to TNF-α inhibition. Despite encouraging efficacy and safety data, complete disease remission remains difficult to achieve, highlighting the need for further therapeutic advances.

5 June 2026 in Quality in Sport
Verified
Journal Article
Open access
PTPaweł Arkadiusz Trzepizur
Paweł Arkadiusz Trzepizur
NSNikola Agnieszka Samp
Nikola Agnieszka Samp
BBBeniamin Andrzej Bekrycht
Beniamin Andrzej Bekrycht
JFJęDrzej Marek Foryński
JęDrzej Marek Foryński
MSMichelle Martina Stachurska
Michelle Martina Stachurska
RWRafał Wilczyński
Rafał Wilczyński
Background. Attention deficit hyperactivity disorder (ADHD) affects approximately 7.2% of children and adolescents internationally and is associated with functional impairment across educational, social, occupational, and health behavioral domains. Despite evidence that physical activity benefits cognition and psychosocial functioning, participation remains markedly insufficient, with only 6.5% of adolescents with ADHD meeting all recommended movement guidelines. Aim. To synthesize evidence on physical activity levels, sport participation, exercise types, barriers and facilitators, sex differences, and dose effects in individuals with ADHD. Material and methods. PubMed search (January 2015 – May 2026); studies reporting physical activity, sport participation, or exercise outcomes in individuals with ADHD. Findings were synthesized narratively. Results. Several forms of physical activity — aerobic exercise, martial arts, racket sports, swimming, equine-assisted activities, target shooting, exergaming, combined aerobic-cognitive exercise, and multicomponent school-based programs — were associated with improvements in cognitive, behavioral, or psychosocial outcomes. Barriers were primarily related to executive dysfunction, motivational difficulties, and low self-esteem; facilitators were largely tied to direct experience of the benefits of exercise. Conclusions. Individuals with ADHD engage in physical activity at markedly insufficient levels and face distinctive barriers rooted in executive dysfunction and motivational dysregulation. Multiple forms of physical activity produced meaningful benefits, suggesting interventions need not be restricted to aerobic exercise alone. Sex-specific factors and exercise intensity warrant explicit consideration in intervention design.

11 July 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
NSNikola Agnieszka Samp
Nikola Agnieszka Samp
PTPaweł Arkadiusz Trzepizur
Paweł Arkadiusz Trzepizur
KZKamila Zera
Kamila Zera
BBBeniamin Andrzej Bekrycht
Beniamin Andrzej Bekrycht
JFJęDrzej Marek Foryński
JęDrzej Marek Foryński
RWRafał Wilczyński
Rafał Wilczyński
Background: ADHD is characterized by inattention, hyperactivity, impulsivity, and affects 8.4% of children and 2.5% of adults. Lower diagnosis rates in females suggest a different clinical presentation, contributing to delayed diagnoses and negative outcomes across multiple domains of functioning. Aim: This study examines underdiagnosed ADHD in women, assessing its impact on functioning in adulthood, including mental health, quality of life, and long-term impairments. Material and methods: A literature review using PubMed/MEDLINE (2010–2025) included clinical, longitudinal cohort, and epidemiological research addressing sex differences in ADHD diagnosis, symptom presentation, and long-term functional outcomes, with a focus on the female population. Results: Women with ADHD are significantly underdiagnosed in childhood, often receiving diagnosis only in adulthood after years of treatment for comorbidities such as anxiety, depression, or personality disorders. Internalized symptoms and emotional dysregulation frequently mask core ADHD features. Late diagnosis is associated with impaired educational and occupational achievement, relationship instability, low self-esteem, substance misuse, reduced quality of life, and increased risk of self-harm and suicide attempts. ADHD in women also increases risk of psychiatric and obstetric complications, including teenage pregnancy, smoking during pregnancy, substance misuse, and postpartum depression and anxiety. Conclusions: Underdiagnosis of ADHD in women remains a significant clinical and public health issue. Greater awareness of sex-specific symptom presentation and improved diagnostic strategies are essential to prevent long-term psychosocial consequences and improve quality of life in affected women.